Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
A lot more females, said Pierre
Wide age range Younger patients (20s and 30s) with congenitally long philtrum are good candidates
A 15-20% premium over tirzepatide would not be unexpected given the additional weight loss achieved
Regulatory Status and Access Considerations BPC-157 has no FDA approval for any indication
Making the Right Choice for Your Situation Each access pathway suits different circumstances
Raking in more than $16 billion, this drug, marketed as Ozempic (Novo Nordisk) and Wegovy (Novo Nordisk), became a household name and highly coveted commodity in the treatment of type 2 diabetes and for weight management, respectively
US$ 22.06
US$ 28.32
US$ 22.71
US$ 20.64
US$ 26.38
US$ 23.37
US$ 23.73
